Thomas A. Keuer - 08 Dec 2022 Form 4 Insider Report for ARCA biopharma, Inc. (ORKA)

Reporting relationship: Chief Operating Officer
Issuer ticker: ORKA
Reported as of: 08 Dec 2022
Net transaction value: $0
SEC form: 4
Accepted by SEC: 09 Dec 2022, 15:30:38 UTC
Prior SEC filing: 16 Dec 2021
Source filing: View source filing
Reporting owner signature: /s/ C. Jeffrey Dekker, Attorney-in-Fact

Key filing fact

Thomas A. Keuer filed Form 4 for ARCA biopharma, Inc. (ORKA) on 09 Dec 2022.

Key facts

This page summarizes Thomas A. Keuer's Form 4 filing for ARCA biopharma, Inc. (ORKA).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 09 Dec 2022, 15:30.

Change

Previous filing in this sequence was filed on 16 Dec 2021.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ABIO transaction

Common Stock

Award

Transaction value: $0
Shares: +40,000
Change %: +5479%
Price: $0.000000
Shares after: 40,730
Date: 08 Dec 2022
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Represents shares issued as restricted stock units (an "RSU") under the Issuer's 2020 Equity Incentive Plan (the "2020 Plan"). The RSUs vest one year from December 8, 2022, subject to continuing employment with the Company through that date. In the event of a change in control of the Issuer or the grantee's involuntary termination without cause or by the grantee for good reason, 100% of the unvested RSUs shall become fully and immediately vested upon the closing date of such change in control or such involuntary termination date, respectively (to the extent such unvested RSUs have not yet then vested).